Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.

GH participates in growth, metabolism, and cellular differentiation. To study these roles, we previously generated two different dwarf mouse lines, one expressing a GH antagonist (GHA) and the other having a disrupted GH receptor and binding protein gene (GHR -/-). In this study we compared the two dwarf lines in the same genetic background (C57BL/6J). One of the most striking differences between the mouse lines was their weight gain profile after weaning. The weights of the GHA dwarfs gradually approached controls over time, but the weights of the GHR -/- dwarfs remained low throughout the analysis period. Additionally, fasting insulin and glucose levels were reduced in the GHR -/- mice but normal in the GHA mice. IGF-I and IGF binding protein 3 (IGFBP-3) levels were significantly reduced, but by different degrees, in both mouse lines, but IGFBP-1 and -4 levels were reduced and IGFBP-2 levels increased in GHR -/- mice but unaltered in GHA mice. Finally, life span was significantly extended for the GHR -/- mice but remained unchanged for GHA dwarfs. These results suggest that the degree of blockade of GH signaling can lead to dramatically different phenotypes.

[1]  A. Bartke Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size. , 2000, Results and problems in cell differentiation.

[2]  D. Ridgway,et al.  Effects of growth hormone antagonists on 3T3-F442A preadipocyte differentiation. , 1995, The Journal of endocrinology.

[3]  Andrzej Bartke,et al.  Dwarf mice and the ageing process , 1996, Nature.

[4]  Matthias Blüher,et al.  Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.

[5]  T. Wagner,et al.  Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. , 1991, Endocrinology.

[6]  J. Knapp,et al.  Growth hormone (GH) receptors, binding proteins and IGF-I concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist. , 1998, The Journal of endocrinology.

[7]  L. Sjöström,et al.  Effects of growth hormone on fat mass and fat distribution. , 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[8]  S. Bennett,et al.  Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  J. Papaconstantinou,et al.  The Snell dwarf mutation Pit1 dw can increase life span in mice , 2002, Mechanisms of Ageing and Development.

[10]  J. Knapp,et al.  The use of transgenic mice in nutrition research. , 1994, The Journal of nutrition.

[11]  E. Froesch,et al.  Production of carrier proteins for insulin‐like growth factors (IGFs) by rat osteoblastic cells Regulation by IGF I and cortisol , 1989, FEBS letters.

[12]  T. Wagner,et al.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. O’Brien,et al.  Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin , 2000, The Journal of Biological Chemistry.

[14]  G. Hubbard,et al.  Aged-rodent models of long-term growth hormone therapy: lack of deleterious effect on longevity. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  K. Sjögren,et al.  Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. , 2000, Biochemical and biophysical research communications.

[16]  E. Hafen,et al.  Dietary Restriction and Life-Span , 2002, Science.

[17]  R. J. Johnson,et al.  Interaction of dietary protein content and exogenous porcine growth hormone administration on protein and lipid accretion rates in growing pigs. , 1990, Journal of animal science.

[18]  P. Kelly,et al.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. , 1974, Endocrinology.

[19]  M. Schreibman,et al.  Vertebrate endocrinology : fundamentals and biomedical implications , 1986 .

[20]  T. Wagner,et al.  Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Powell,et al.  Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells. , 1992, Biology of reproduction.

[22]  M. Pines,et al.  Growth hormone (GH) action in early embryogenesis: expression of a GH-response gene in sites of GH production and action , 2001, Anatomy and Embryology.

[23]  H. Green,et al.  The generation of insulin-like growth factor-1--sensitive cells by growth hormone action. , 1986, Science.

[24]  C. Hsieh,et al.  Effects of the Pit1 mutation on the insulin signaling pathway: implications on the longevity of the long-lived Snell dwarf mouse , 2002, Mechanisms of Ageing and Development.

[25]  L. Giudice,et al.  Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  C. Hsieh,et al.  Implications for the insulin signaling pathway in Snell dwarf mouse longevity: a similarity with the C. elegans longevity paradigm , 2002, Mechanisms of Ageing and Development.

[27]  L. Phillips,et al.  Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. , 1998, Progress in nucleic acid research and molecular biology.

[28]  M. Davidson Effect of growth hormone on carbohydrate and lipid metabolism. , 1987, Endocrine reviews.

[29]  T. Shepard,et al.  Human growth hormone , 1960 .

[30]  S. Handwerger,et al.  Three distinct forms of insulin-like growth factor binding proteins are released by decidual cells in culture. , 1990, Endocrinology.

[31]  A. Bartke,et al.  Reduced Levels of Thyroid Hormones, Insulin, and Glucose, and Lower Body Core Temperature in the Growth Hormone Receptor/Binding Protein Knockout Mouse , 2001, Experimental biology and medicine.

[32]  M. Ridderstråle,et al.  Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. , 1995, Endocrinology.

[33]  P. R. Johnson,et al.  Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype. , 1997, Growth, development, and aging : GDA.

[34]  A. Frantz,et al.  HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS. , 1964 .

[35]  D. Powell,et al.  Activation of the insulin-like growth factor binding protein-1 promoter by progesterone receptor in decidualized human endometrial stromal cells , 1999, Molecular and Cellular Endocrinology.

[36]  Z. Laron,et al.  The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. , 1999, The Journal of clinical endocrinology and metabolism.

[37]  J. Kopchick,et al.  Transgenic models of growth hormone action. , 1999, Annual review of nutrition.

[38]  J. Guevara-Aguirre,et al.  Growth hormone (GH) insensitivity due to primary GH receptor deficiency. , 1994, Endocrine reviews.

[39]  S. Mohan,et al.  Serum Levels of Insulin‐like Growth Factor Binding Proteins (IGFBP)–4 and –5 Correlate with Bone Mineral Density in Growth Hormone (GH)–Deficient Adults and Increase with GH Replacement Therapy , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Z. Laron,et al.  Insulin Resistance in Laron Syndrome (Primary Insulin-like Growth Factor-I (IGF-I) Deficiency) and Effect of IGF-I Replacement Therapy , 1997 .

[41]  R. Nachreiner,et al.  Effects of underfeeding and refeeding on GH and thyroid hormone secretion in young, middle-aged, and old rats , 1990, Experimental Gerontology.

[42]  Z. Laron,et al.  Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. , 1993, Hormone research.

[43]  T. Parr Insulin Exposure and Unifying Aging , 1999, Gerontology.

[44]  J. Kopchick,et al.  A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes. , 1992, Endocrinology.

[45]  G. Striker,et al.  Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. , 1995, Endocrinology.

[46]  Richard A. Miller,et al.  Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K.,et al.  Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. , 1990, The Journal of biological chemistry.

[48]  F. Dominici,et al.  Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. , 2000, The Journal of endocrinology.

[49]  J. A. Scarlett,et al.  Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. , 1999, Diabetes.

[50]  J. Meites Aging: Hypothalamic Catecholamines, Neuroendocrine-Immune Interactions, and Dietary Restriction , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[51]  C. Carter,et al.  A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. , 2002, Trends in genetics : TIG.

[52]  R. Marcus,et al.  Bone Mineral, Histomorphometry, and Body Composition in Adults with Growth Hormone Receptor Deficiency , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  W. Kiess,et al.  Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats , 1992, Diabetologia.

[54]  D. Clemmons,et al.  Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. , 2000, Endocrinology.

[55]  B. Cochran,et al.  Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes. , 1990, Endocrinology.

[56]  C. Breese,et al.  Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. , 1991, Journal of gerontology.

[57]  C. Ohlsson,et al.  Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. , 1993, Endocrinology.

[58]  R. Baron,et al.  Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. , 2000, The Journal of clinical investigation.

[59]  J. Knapp,et al.  Enlargement of Interscapular Brown Adipose Tissue in Growth Hormone Antagonist Transgenic and in Growth Hormone Receptor Gene-Disrupted Dwarf Mice , 2003, Experimental biology and medicine.

[60]  M. Ontell,et al.  Morphometric analysis of the developing mouse soleus muscle. , 1988, The American journal of anatomy.

[61]  R. Leibel,et al.  Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. , 1989, The Journal of clinical endocrinology and metabolism.

[62]  T. Wagner,et al.  Glycine 119 of bovine growth hormone is critical for growth-promoting activity. , 1991, Molecular endocrinology.

[63]  F. Talamantes,et al.  6 – The Growth Hormone Receptor and Growth Hormone-Binding Protein: Structure, Functions, and Regulation , 1993 .

[64]  L. Donahue,et al.  Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. , 1993, The Journal of endocrinology.

[65]  D. Flint,et al.  Influence of growth hormone deficiency on growth and body composition in rats: site-specific effects upon adipose tissue development. , 1993, The Journal of endocrinology.

[66]  T. Parr Insulin exposure and aging theory. , 1997, Gerontology.

[67]  M. Binoux,et al.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.

[68]  R. Leibel,et al.  Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature. , 1992, The Journal of clinical endocrinology and metabolism.

[69]  J. Kopchick,et al.  Growth hormone (GH), GH receptor, and signal transduction. , 2000, Molecular genetics and metabolism.

[70]  J. Shafer,et al.  Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types. , 1990, Endocrinology.

[71]  T. Unterman,et al.  Multihormonal regulation of insulin-like growth factor-binding protein-1 in rat H4IIE hepatoma cells: the dominant role of insulin. , 1991, Endocrinology.

[72]  F. Dominici,et al.  Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. , 2002, The Journal of endocrinology.

[73]  A. Fazleabas,et al.  Interleukin-1β Induces the Expression of Insulin-Like Growth Factor Binding Protein-1 during Decidualization in the Primate* *This work was supported by NIH Grant HD-36759. , 2000, Endocrinology.

[74]  G. Striker,et al.  Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice. , 2000, Endocrinology.

[75]  J. Runstadler,et al.  Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. , 2001, Obesity research.

[76]  M. Waters,et al.  Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? , 1992, Development.

[77]  M. Rechler,et al.  Insulin rapidly inhibits insulin-like growth factor-binding protein-1 gene expression in H4-II-E rat hepatoma cells. , 1991, Molecular endocrinology.

[78]  J. Knapp,et al.  Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. , 1994, Journal of animal science.

[79]  D. Clemmons,et al.  Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. , 1991, Endocrinology.

[80]  J. Jansson,et al.  Mode of action of pituitary growth hormone on target cells. , 1985, Annual review of physiology.